Organ-specific modification of tumor development by low-dose combinations of agents in a rat wide-spectrum carcinogenesis model
- PMID: 1908845
- PMCID: PMC5918544
- DOI: 10.1111/j.1349-7006.1991.tb02703.x
Organ-specific modification of tumor development by low-dose combinations of agents in a rat wide-spectrum carcinogenesis model
Abstract
The combined effects of low doses of various carcinogens and carcinogenesis modifiers on tumor development were investigated by using a wide-spectrum organ carcinogenesis model in F344 rats. These agents were administered as three groups: (1) a group of known hepatocarcinogens; (2) a group of nitroso compounds having various target organ specificities; and (3) a group of antioxidants having various inhibiting or enhancing activities depending on the target organ. Doses were used which were generally below the known effective level for the individual chemical. These groups of chemicals were administered with or without prior administration of N-diethylnitrosamine (100 mg/kg body wt., i.p.), N-methylnitrosourea (4 x 20 mg/kg body wt., i.p.) and dihydroxy-di-N-propylnitrosamine (0.1% in drinking water for 2 weeks). The hepatocarcinogen group in combination with various nitroso compounds increased the incidences of liver hyperplastic nodules and hepatocellular carcinomas. In contrast, incidences were clearly reduced when the hepatocarcinogens and/or the nitroso compounds were administered in combination with the antioxidants. For the urinary bladder, the combination with nitroso compounds and antioxidants enhanced cancer development, and the addition of hepatocarcinogens further increased tumorigenesis. For the glandular stomach, additive effects on the numbers of pepsinogen isozyme 1-altered pyloric glands, a putative preneoplastic lesion, were produced by the combination treatment of antioxidants and the nitroso compounds. No synergistic effects on tumor development were seen in other organs. The results of the present study demonstrated that combinations of various compounds at low doses can additively or synergistically exert either enhancing or inhibitory effects on the development of preneoplastic and neoplastic lesions in different organs in a single model having a wide spectrum of organ effects.
Similar articles
-
Modifying effects of simultaneous treatment with butylated hydroxyanisole (BHA) on rat tumor induction by 3,2'-dimethyl-4-aminobiphenyl, 2,2'-dihydroxy-di-n-propylnitrosamine and N-methylnitrosourea.Carcinogenesis. 1989 Dec;10(12):2255-9. doi: 10.1093/carcin/10.12.2255. Carcinogenesis. 1989. PMID: 2591015
-
Carcinogenicity of antioxidants BHA, caffeic acid, sesamol, 4-methoxyphenol and catechol at low doses, either alone or in combination, and modulation of their effects in a rat medium-term multi-organ carcinogenesis model.Carcinogenesis. 1998 Jan;19(1):207-12. doi: 10.1093/carcin/19.1.207. Carcinogenesis. 1998. PMID: 9472713
-
Enhancing effects of sodium phenobarbital and N,N-dibutylnitrosamine on tumor development in a rat wide-spectrum organ carcinogenesis model.Carcinogenesis. 1990 Jun;11(6):1027-31. doi: 10.1093/carcin/11.6.1027. Carcinogenesis. 1990. PMID: 2347061
-
Experimental prostate carcinogenesis - rodent models.Mutat Res. 2000 Apr;462(2-3):219-26. doi: 10.1016/s1383-5742(00)00039-9. Mutat Res. 2000. PMID: 10767633 Review.
-
Possible carcinogenic potential of dimethylarsinic acid as assessed in rat in vivo models: a review.Mutat Res. 1997 Jun;386(3):353-61. doi: 10.1016/s1383-5742(97)00017-3. Mutat Res. 1997. PMID: 9219572 Review.
Cited by
-
Correlation between medium-term multi-organ carcinogenesis bioassay data and long-term observation results in rats.Jpn J Cancer Res. 1993 Mar;84(3):237-45. doi: 10.1111/j.1349-7006.1993.tb02862.x. Jpn J Cancer Res. 1993. PMID: 8486526 Free PMC article.
-
Modifying effects of various chemicals on tumor development in a rat wide-spectrum organ carcinogenesis model.Jpn J Cancer Res. 1992 Aug;83(8):812-20. doi: 10.1111/j.1349-7006.1992.tb01985.x. Jpn J Cancer Res. 1992. PMID: 1399818 Free PMC article.
References
-
- ) Macdonald , J. C , Miller , E. C. , Miller , J. A. and Rush , H. P.Synergistic action of mixtures of certain hepatic carcinogens . Cancer Res. , 12 , 50 – 54 ( 1952. ). - PubMed
-
- ) Tatematsu , M. , Miyata , Y. , Mizutani , M. , Hananouchi , M. , Hirose , M. and Ito , N.Summation effect of N‐butyl‐N‐(4‐hydroxybutyl)nitrosamine, N‐[4‐(5‐nitro‐2‐furyl)‐2‐thiazolyl] formamide, N‐2‐fluorenylacetamrde, and 3‐3‐dichlorobenzidine on urinary bladder carcinogenesis in rats . Gann , 68 , 193 – 202 ( 1977. ). - PubMed
-
- ) Tsuda , H. , Miyata , Y. , Murasaki , G. , Kinoshita , H. , Fukushima , S. and Ito , N.Synergistic effect of urinary bladder carcinogenesis in rats treated with N‐butyl‐N‐(4‐hydroxybutyl)nitrosamine, N‐[4‐(5‐nitro‐2‐furyl)‐2‐thiazolyl]formamide, N‐2‐fluorenylacetamide, and 3,3‐dichlorobenzidine . Gann , 68 , 183 – 192 ( 1977. ). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources